The Cascade Feasibility Pilot (Ileostomy)

December 9, 2021 updated by: Nirav Shah, NorthShore University HealthSystem

The Cascade Feasibility Pilot (Ileostomy): Improving Care Processes for New Ileostomy Patients Using Continuous Remote Patient Monitoring and a Cascading Alert System

Existing interventions including improving communication and self-care to improve readmission of patients undergoing high risk colorectal surgery involving new ileostomy formation has shown limited results. Our proposal is to deploy a wearable solution that predicts physiological perturbation with continuous remote patient monitoring and advanced machine learning algorithms which will be connected to structured, cascading, escalation pathways and care coordination involving home health nurses, colorectal and ostomy nurses, and colorectal surgeons, and has the potential to transform surgical management in the post-discharge period, where patients are the most vulnerable for readmission. This feasibility study will contribute to the understanding of post-discharge continuous remote monitoring of ileostomy patients, promote patient self-care, and has the potential of improving patient outcomes.

Study Overview

Detailed Description

Colorectal surgery is a high-risk surgery that results in significant morbidity, and health care utilization in the form of readmission. Ileostomy creation is a significant risk factor in colorectal surgery rehospitalization. Effective continuous remote patient monitoring (CRPM) can reduce readmissions, but it has only been realized in select heart failure populations via invasive monitoring. The investigators will focus on colorectal CRPM in the elective, new ileostomy population through a structured cascading and escalating alert system. In this feasibility study, the investigators will use a wearable biosensor and collect ambulatory physiological data that are analyzed by machine learning algorithms, to generate personalized alerts of physiological perturbation in colorectal surgery patients in the post-discharge period. Alerts from this algorithm may be cascaded with other patient status data to inform management by the home health team via a structured protocol built into the electronic health record (EHR). The escalation pathway will engage home health nurses, colorectal care team nurses, ostomy nurses, and colorectal surgeons. The investigators will conduct surveys and semi-structured interviews with patients, and semi-structured interviews with providers, which will be used to evaluate the perceptions, acceptance, and experience of this CRPM solution.

Study Type

Interventional

Enrollment (Anticipated)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Illinois
      • Evanston, Illinois, United States, 60201
        • Recruiting
        • NorthShore University HealthSystem Evanston Hospital
      • Glenview, Illinois, United States, 60201
        • Recruiting
        • NorthShore University HealthSystem Glenbrook Hospital
        • Contact:
      • Highland Park, Illinois, United States, 60035-2558
        • Recruiting
        • NorthShore University HealthSystem HighlandPark Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient is inpatient admission at NorthShore University HealthSystem hospital
  • Patient underwent a new ileostomy formation at index hospitalization
  • Patient is at least 18 years of age
  • Patient is fluent in English
  • Patient agrees to protocol-required procedures
  • Patient discharges with NorthShore Home Health Service

Exclusion Criteria:

  • Patient has cognitive or physical limitations that, in the investigator's opinion, limit the patient's ability to maintain patch device and phone
  • Patient has allergy to hydrocolloid adhesives
  • Patient has present skin damage preventing them from wearing a study device
  • Pregnancy
  • Patient discharge location is a Skilled Nursing Facility or other subacute facilities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NON_RANDOMIZED
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Soft Launch
The study will include ten eligible patients into the soft launch to test and reconfigure workflow, protocol, alerting structure and other operation related factors.
Continuous patient monitoring through non-invasive biosensors coupled with machine learning algorithms, with a structured escalation and communication pathway for home health providers and colorectal clinical team
Surveys and interviews with enrolled participants
EXPERIMENTAL: Pilot
After the soft launch, the study will include 45 eligible patients into the pilot to conduct the rest of the study
Continuous patient monitoring through non-invasive biosensors coupled with machine learning algorithms, with a structured escalation and communication pathway for home health providers and colorectal clinical team
Surveys and interviews with enrolled participants

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attrition rate
Time Frame: Through study completion, an average 2 year
Drop out from study
Through study completion, an average 2 year
Enrollment rate
Time Frame: Through study completion, an average 2 year
Enrollment rate for entire patient cohort
Through study completion, an average 2 year
Adherence to study requirement rate
Time Frame: Through study completion, an average 2 year
Patient adherence to patch, daily patient reported status updates and other study requirements
Through study completion, an average 2 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Documented Medication adherence counseling
Time Frame: 30 days from patient discharge date
Frequency of medication adherence counseling captured in a note within the electronic health record
30 days from patient discharge date
Documented Dietary counseling
Time Frame: 30 days from patient discharge date
Frequency of dietary counseling captured in a note within the electronic health record
30 days from patient discharge date
Stool regimen escalation
Time Frame: 30 days from patient discharge date
Frequency of augmenting stool regimen dosage
30 days from patient discharge date

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 9, 2021

Primary Completion (ANTICIPATED)

August 31, 2023

Study Completion (ANTICIPATED)

August 31, 2023

Study Registration Dates

First Submitted

September 8, 2021

First Submitted That Met QC Criteria

September 8, 2021

First Posted (ACTUAL)

September 17, 2021

Study Record Updates

Last Update Posted (ACTUAL)

December 30, 2021

Last Update Submitted That Met QC Criteria

December 9, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Cascade Ileostomy

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ileostomy; Complications

Clinical Trials on Non-invasive continuous remote monitoring with structured escalation pathway

3
Subscribe